NIH BIOBANKING EXPERT JOINS VASCULAR CURES SCIENTIFIC ADVISORY BOARD

Media Contact: Wendy R. Hitchcock
Chief Executive Officer
650.368.6022
This email address is being protected from spambots. You need JavaScript enabled to view it.

Jodi B. Black, PhD, MMSc, National Leader in Cardiovascular and Genomics Research
January 25, 2012 – Vascular Cures, a non-profit leader in developing innovative treatments for vascular disease, announced that Dr. Jodi B. Black has joined its Scientific Advisory Board. Dr. Black is Deputy Director, Division of Extramural Research Activities (DERA) for the National Heart, Lung, and Blood Institute (NHLBI) of the National Institutes of Health (NIH). The NHLBI provides global leadership to promote research into the prevention, treatment and understanding of heart, lung, and blood diseases. AsDeputy Director for DERA, Dr. Black provides scientific and management oversight of the NHLBI’s $2.8 billion research portfolio.

“We want to change the way we care for patients by developing treatments that address their unique genetic and biological makeup,” said Michael S. Conte, MD, Vascular Cures’ Chief Medical Officer and Chief of the Division of Vascular and Endovascular Surgery at the University of California, San Francisco. “This is the aim of the Vascular Cures Research Network (VCRN), a multi-institutional research consortium creating the first national vascular biobank of tissues from 2000 patients. Dr. Black’s unique expertise in translational and genomics research and multi-disciplinary scientific programs will be of tremendous value in accelerating this program.”

“The Vascular Cures Research Network and biobank have the potential to transform how we treat and prevent vascular disease,” said Dr. Black. “Collaboration between world-class institutions and a robust biobank are the best way to drive innovation in personalized medicine for vascular disease, and I’m very happy to be part of the leadership team.”

Dr. Black also serves as the Acting Director of the NHLBI Office of Translational Alliances and Coordination, and is on the Program Committee for the International Society for Biological and Environmental Repositories (ISBER), promoting innovation, quality and ethical standards for global biobanking.

The first project of the Vascular Cures Research Network is to determine the factors affecting vascular healing after treatments to restore blood flow in the legs. The most common treatments for patients with blocked arteries are angioplasty, stents and bypass surgery, but up to half of these fail within a few years due to abnormal healing and scarring, requiring repeat procedures that are expensive and traumatizing to patients. Dr. Conte and a collaborator from VCRN recently identified the first genetic marker to predict outcomes of patients undergoing bypass surgery in the legs.

About the Vascular Cures Research Network (VCRN)
The Vascular Cures Research Network is the first national vascular research consortium of vascular specialists at world-class medical institutions. Members of this collaborative team are sharing information and results in order to accelerate the development of new drugs, technologies and predictive tools to improve treatments for vascular disease.

About Vascular Cures
A leader in vascular research, Vascular Cures invests in the development of breakthrough treatments to prevent disability and death from vascular disease, the #1 cause of disability and death. Strokes, heart attacks, aneurysms, peripheral artery disease (PAD), blood clots, and pulmonary embolisms are all the result of problems along the vascular “highways” in the body. Research by our network of leading surgeon-scientists is advancing the development of powerful new ways to predict, treat and prevent vascular disease. For more information visit www.vascularcures.org.